Trial intelligence / Profile preview

Placebo-controlled baclofen trial in rumination syndrome and supragastric belching

2011-002745-35Phase 4Completed

Sponsor
UZ Leuven
Start
Aug 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in rumination disorder and supragastric belching (SGB) comparing Baclofen arm with Placebo arm (2 arms). Primary endpoint: Occurrence of gas and liquid flow events and symptoms during manometry-impedance recordings. Started Aug 2011; status: completed.

02

Drugs

baclofen
03

Conditions

rumination disordersupragastric belching (SGB)

Beyond the preview

Go deeper on 2011-002745-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-002745-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call